Emerging Chemotherapy Targets: Insights from Advances in Glioma Treatment
Open Access
- 12 June 2025
- journal article
- review article
- Published by MDPI AG in Biomedicines
- Vol. 13 (6) , 1452
Abstract
Primary brain tumors represent a significant focus of contemporary research. With advancements in technology and the increasing detection of cases through novel diagnostic methods, innovative therapies and approaches to chemotherapy continue to emerge. The paper explores recent advancements in chemotherapy for glioblastoma, highlighting innovative approaches that provide valuable mechanistic insights. It delves into the mechanisms of action, molecular targets, and the future potential of emerging therapies for gliomas. Additionally, this paper offers an overview investigating a range of therapies, including various chemotherapeutic agents, CAR-T cell therapies, drugs targeting cellular respiration, and other approaches. Furthermore, the paper addresses chemotherapy-related challenges, including the blood–brain barrier, drug resistance, and immunosuppression, while proposing potential solutions to overcome these obstacles.Keywords
This publication has 78 references indexed in Scilit:
- Causal Association of Cytokines and Growth Factors with Stroke and Its Subtypes: a Mendelian Randomization StudyMolecular Neurobiology, 2023
- Inhibition of SHP2 as an approach to block RAS-driven cancers2022
- Intrathecal drug delivery in the era of nanomedicineAdvanced Drug Delivery Reviews, 2020
- Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG)Journal of Neuro-Oncology, 2019
- HER2-Specific Chimeric Antigen Receptor–Modified Virus-Specific T Cells for Progressive GlioblastomaJAMA Oncology, 2017
- Nanotherapeutic systems for local treatment of brain tumorsWIREs Nanomedicine and Nanobiotechnology, 2017
- A Review of the Economic Burden of Glioblastoma and the Cost Effectiveness of Pharmacologic TreatmentsPharmacoEconomics, 2014
- AVAglio: Phase 3 trial of bevacizumab plus temozolomide and radiotherapy in newly diagnosed glioblastoma multiformeAdvances in Therapy, 2011
- Vascular Endothelial Growth Factor Increases Permeability of the Blood–Tumor Barrier via Caveolae-Mediated Transcellular PathwayJournal of Molecular Neuroscience, 2010
- Drug delivery to brain tumorsCurrent Neurology and Neuroscience Reports, 2008